EEF1A1 and gastric adenocarcinoma: In a total of 104 gastric adenocarcinoma specimens, 55 (52.9%) showed high EF-Tu expression, 39 (41.3%) showed weak EF-Tu expression and 6 (5.8%) showed absence of EF-Tu expression (Figure 1).